GENE ONLINE|News &
Opinion
Blog

Coronavirus
COVID-19 Vaccine
COVID-19 Vaccine: Russia Announces Approval of “Sputnik V” Despite Concerns Over Safety
2020-08-12
COVID-19
Novavax’s COVID-19 Vaccine is Safe and Immunogenic in Early Trial
2020-08-06
COVID-19
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
Innovative Diagnostics, AI, Blockchain and Telemedicine Boosts COVID-19 Fight
2020-07-26Partner
COVID-19 Taiwan
Efforts Behind the Taiwan Model of Combating COVID-19 Pandemic
2020-07-26Partner
COVID-19
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19
COVID-19: Medicago Begins Phase I Trials for Plant-Based VLP Vaccine
2020-07-19
COVID-19
Pfizer & BioNTech’s COVID-19 Vaccine Receives FDA’s Fast Track Designation
2020-07-15
COVID-19
Novavax to Deliver 100 Million COVID-19 Vaccine Doses by January 2021
2020-07-12
COVID-19
Regeneron Secures $4.5 Billion Worth of Contracts from the US for Combating COVID-19
2020-07-10
COVID-19
Pfizer and BioNTech’s COVID-19 Vaccine Shows Encouraging Results
2020-07-05
COVID-19 Vaccine
COVAXIN- India’s First Indigenous Vaccine Approved for Human Trials
2020-07-02
COVID-19 Spike Protein
COVID-19: Discovery of New Spike Protein Neutralizing Antibody Reveals Promising Drug Target
2020-06-28
COVID-19 Baricitinib
Eli Lilly Launches Phase 3 Trial with Baricitinib for COVID-19 Patients
2020-06-26
COVID-19
BIO Digital 2020 Highlights: Global Solutions for Implementation: From Scale-up to Worldwide Access
2020-06-24
1 … 6 7 8 9 10 … 13
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top